RJ Hamster
CSE: ALEN.U is targeting a fast-growing digital wellness market
| UnsubscribeFrom our partners at EquiscreenAleen Inc. (CSE: ALEN.U) is developing an AI-powered wellness intelligence platform aimed at the rapidly expanding digital health and wellness market.The company’s non-medical platform uses artificial intelligence to transform anonymous wellness inputs into personalized, easy-to-understand insights focused on awareness and reflection. Rather than making clinical claims, Aleen is positioning itself around clarity, transparency, and responsible AI, which is a key distinction in today’s wellness landscape.The global digital health and wellness market continues to expand as consumers increasingly rely on technology to better understand personal wellness data. Aleen is building a scalable platform designed to participate in this shift without crossing into regulated medical territory.What makes Aleen interesting from an investor standpoint is scalability. The platform includes an AI-driven API that allows digital wellness platforms and applications to integrate Aleen’s insights directly into their own offerings, creating potential for broader adoption as demand grows.This is an early-stage company targeting a fast-growing segment, with AI as the engine and simplicity as the differentiator.Take a closer look at how Aleen Inc. (CSE: ALEN.U) is positioning itself in the AI-driven wellness space. Special ReportMeta Platforms Posted Its Fastest Growth Guide in Years—Now What?Written by Leo Miller. Published: 2/3/2026. Key TakeawaysMeta’s latest earnings report swayed many investors, as shares rose by a double-digit percentage the next day.The company’s Q1 2026 guidance implies growth that the company has not seen in years, especially when adjusting for pandemic-driven abnormalities.Updated price targets imply +20% upside ahead, with one particularly bullish forecast projecting +50% gains.All things considered, Meta Platforms (NASDAQ: META) delivered a very strong Q4 2025 earnings report. In its Jan. 28 release the company comfortably surpassed estimates for revenue and adjusted earnings per share (EPS), and it showed meaningful underlying improvements in the business.The Magnificent Seven company’s outlook was especially notable. Despite forecasting rapidly rising spending in 2026, Meta projected that sales would increase 30% in Q1 2026 — its fastest pace since Q3 2021. Wall Street responded by raising price targets, reflecting growing confidence in the company’s growth trajectory.Growth at Scale: Putting Meta’s 30% Guidance in ContextThe Silver Strategy Hiding Inside IRAs (Ad)In 2000, I told Barron’s that a popular dot-com stock was headed for trouble. It dropped 90%. Now I’m making the opposite call on that same company: buy it now. This stock has become the lifeblood of AI data centers, yet almost no one has caught the story. While the media focuses on AI chip wars, they’ve missed this company’s essential role in building out data centers. Their hardware is so critical that a single building uses enough of it to stretch around the world eight times. If you own Nvidia, you might want to pivot. If you missed Nvidia, this is your second chance at the AI data center buildout happening worldwide.See the under-the-radar play fueling AI data centersMeta has not posted 30% growth since Q3 2021 — more than four years ago — which already underscores how strong the guidance is. A closer look makes the outlook even more impressive.The results many companies reported in 2021 were influenced by an unusual variable: the COVID-19 pandemic. With the economy effectively shut down in 2020, that year was unusually weak for many businesses, including Meta. In 2020 Meta’s sales rose almost 22% — at the time its slowest growth rate since at least 2015.When demand rebounded in 2021, sales spiked, and year-over-year comparisons to 2020 were easier. Because 2021 benefited from those pandemic-era comparables, it’s useful to consider Meta’s guidance against pre-pandemic periods.Excluding 2020 and 2021, Meta has not achieved a 30% growth rate since Q4 2018 — roughly seven years ago. That’s notable because Meta’s revenue base is much larger today, and as revenues grow, sustaining high percentage growth becomes harder: each incremental dollar has less impact on a bigger total.If Meta delivers 30% growth next quarter, sales would be near $55 billion. By contrast, when Meta posted roughly 30% growth in Q4 2018, revenue was just $16.9 billion. That gap highlights how substantial the company’s opportunities are today — Meta expects to produce similar growth off a revenue base more than three times larger.Meta Price Targets Rise, Most Bullish Forecast Pushed HigherThe MarketBeat consensus price target on Meta shares sits near $849, implying roughly 20% upside. Looking at updates after the Jan. 28 results paints an even brighter picture: MarketBeat tracked more than 25 analysts who revised their targets after the earnings release, and all but one raised theirs. The average updated target was $870, implying about 23% upside.Analysts have generally remained bullish even when some investors were cautious. For example, the average of price targets updated one week after the company’s Q3 2025 report was $857, despite the stock falling more than 10% during that period.The lowest post-Jan. 28 target tracked by MarketBeat comes from Scotiabank at $700, implying roughly 1% downside versus the stock’s Feb. 2 close near $706. The most bullish updated target comes from Rosenblatt Securities, which raised its forecast to $1,144 (it had been $1,117). That target implies nearly 62% upside.Historically Conservative Forecasts Provide Potential for Upward RevisionsMeta’s Q4 report helped restore investor confidence: shares rose 10.4% the next day, and most Wall Street analysts remain constructive. Notably, the company has beaten sales estimates in each of its last 14 earnings releases.That consistent track record supports the case for further upward revisions to price targets, but markets will continue to watch Meta’s spending closely and will expect the company to execute on its ambitious growth projections. This email is a sponsored email sent on behalf of Equiscreen, a third-party advertiser of MarketBeat. Why was I sent this email message?. This message is a paid advertisement for Aleen Inc. (CSE: ALEN.U) from Equiscreen and Interactive Offers. MarketBeat Media, LLC receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $1,000. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either Equiscreen or Interactive Offers. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Aleen Inc. (CSE: ALEN.U) on Interactive Offers’ website for additional information about the relationship between Interactive Offers and Aleen Inc. (CSE: ALEN.U). If you need assistance with your subscription, please don’t hesitate to contact our South Dakota based support team at contact@marketbeat.com. If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here. © 2006-2026 MarketBeat Media, LLC. 345 N Reid Pl., Sixth Floor, Sioux Falls, S.D. 57103-7078. USA..Today’s Featured Link: Trump’s Final Shocking Act Begins February 24 (From Banyan Hill Publishing) |
